» Articles » PMID: 18579178

Requirements of the Membrane Proximal Tyrosine and Dileucine-based Sorting Signals for Efficient Transport of the Subtype C Vpu Protein to the Plasma Membrane and in Virus Release

Overview
Journal Virology
Specialty Microbiology
Date 2008 Jun 27
PMID 18579178
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Previously, we showed that the Vpu protein from HIV-1 subtype C is more efficiently transported to the cell surface than the well studied subtype B Vpu (Pacyniak et al., 2005) and that a SHIV expressing the subtype C Vpu exhibited a decreased rate of CD4+ T cell loss following inoculation in macaques (Hill et al., 2008). In this study, we examined the role of overlapping tyrosine-based (YXXPhi) and dileucine-based ([D/E]XXXL[L/I]) motifs in the membrane proximal region of the subtype C Vpu (EYRKLL) in Vpu intracellular transport, CD4 surface expression and virus release from the cell surface. We constructed three site-directed mutants of the subtype C vpu and fused these genes to the gene for enhanced green fluorescent protein (EGFP). The first mutation made altered the tyrosine (EARKLL; VpuSCEGFPY35A), the second altered the dileucine motif (EYRKLG; VpuSCEGFPL39G), and the third contained both amino acid substitutions (EARKLG; VpuSCEGFPYL35,39AG) in this region of the Vpu protein. The VpuSCEGFPY35A protein was transported to the cell surface similar to the unmodified VpuSCEGFP1 while VpuSCEGFPL39G was expressed at the cell surface at significantly reduced levels. The VpuSCEGFPYL35,39AG was found to have an intermediate level of cell surface expression. All three mutant Vpu proteins were analyzed for the ability to prevent cell surface expression of CD4. We found that both single mutants did not significantly effect CD4 surface expression while the double mutant (VpuSCEGFPYL35,39AG) was significantly less efficient at preventing cell surface CD4 expression. Chimeric simian human immunodeficiency viruses were constructed with these mutations in vpu (SHIVSCVpuY35A, SHIVSCVpuL39G and SHIVSCVpuYL35,39AG). Our results indicate that SHIVSCVpuL39G replicated much more efficiently and was much more cytopathic than SHIVSCVpu. In contrast, SHIVSCVpuY35A and SHIVSCVpuYL35,39AG replicated less efficiently when compared to the parental SHIVSCVpu. Taken together, these results show for the first time that the membrane proximal tyrosine-based sorting motif in the cytoplasmic domain of Vpu is essential for efficient virus release. These results also indicate that the dileucine-based sorting motif affects the intracellular trafficking of subtype C Vpu proteins, virus replication, and release.

Citing Articles

Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease.

Gargan S, Stevenson N Viruses. 2021; 13(11).

PMID: 34834972 PMC: 8618147. DOI: 10.3390/v13112165.


Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis.

Khan N, Geiger J Viruses. 2021; 13(8).

PMID: 34452331 PMC: 8402909. DOI: 10.3390/v13081466.


The C-Terminal End of HIV-1 Vpu Has a Clade-Specific Determinant That Antagonizes BST-2 and Facilitates Virion Release.

Sharma S, Jafari M, Bangar A, William K, Guatelli J, Lewinski M J Virol. 2019; 93(11).

PMID: 30867310 PMC: 6532089. DOI: 10.1128/JVI.02315-18.


Endocytic activity of HIV-1 Vpu: Phosphoserine-dependent interactions with clathrin adaptors.

Stoneham C, Singh R, Jia X, Xiong Y, Guatelli J Traffic. 2017; 18(8):545-561.

PMID: 28504462 PMC: 5600163. DOI: 10.1111/tra.12495.


Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates.

Chen C, Shingai M, Welbourn S, Martin M, Borrego P, Taveira N J Virol. 2016; 90(24):11062-11074.

PMID: 27681141 PMC: 5126365. DOI: 10.1128/JVI.01451-16.


References
1.
Maldarelli F, Chen M, Willey R, Strebel K . Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J Virol. 1993; 67(8):5056-61. PMC: 237897. DOI: 10.1128/JVI.67.8.5056-5061.1993. View

2.
Schubert U, Bour S, Ferrer-Montiel A, Montal M, Maldarell F, Strebel K . The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J Virol. 1996; 70(2):809-19. PMC: 189883. DOI: 10.1128/JVI.70.2.809-819.1996. View

3.
Stephens E, McCormick C, Pacyniak E, Griffin D, Pinson D, Sun F . Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques. Virology. 2002; 293(2):252-61. DOI: 10.1006/viro.2001.1244. View

4.
Ewart G, Mills K, Cox G, Gage P . Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu. Eur Biophys J. 2002; 31(1):26-35. DOI: 10.1007/s002490100177. View

5.
Miranda K, Khromykh T, Christy P, Le T, Gottardi C, Yap A . A dileucine motif targets E-cadherin to the basolateral cell surface in Madin-Darby canine kidney and LLC-PK1 epithelial cells. J Biol Chem. 2001; 276(25):22565-72. DOI: 10.1074/jbc.M101907200. View